業績

• 2026年
• 2025年
• 2024年
• 2023年
• 2022年
• 2021年
• 2020年
• 2019年
• 2018年
• 2017年
• 2016年
• 2015年
• 2014年
• 2013年
• 2012年
• 2011年
• 2010年
• 2009年
• 2008年
• 2007年
• 2006年

2026年

• 原著
• 症例報告
• その他

原著

• Okamura K, Tsuneyoshi S, Kitamura H, Hamashoji T, Yamada S, Tsuruya K, Ago T, Nakano T.

  Associations between the Cardiothoracic Ratio and All-Cause and Cardiovascular Mortality in Patients Undergoing Peritoneal Dialysis: Fukuoka Peritoneal Dialysis Registry (F-PDR) Study.

  Kidney Dis (Basel). 2026 Apr 25;12(1):413-423.

• Suenaga T, Tanaka S, Kitamura H, Okamura K, Yamada S, Tsuruya K, Nakano T, Ago T.

  Sex-Specific Cardiovascular Risk of Lower Potassium Intake in Patients with CKD.

  Eur J Prev Cardiol in press

• Yamada S, Arase H, Tokumoto M, Taniguchi M, Tsuruya K, Nakano T, Ago T.

  Hyperphosphatemia-Related Mortality Is Modified by Serum Albumin and Creatinine Levels in Hemodialysis Patients: The Q-Cohort Study.

  J Ren Nutr 2026 in press

• Hirashima Y, Yamada S, Kitamura H, Hiyamuta H, Taniguchi M, Tsuruya K, Ago T, Nakano T.

  High-sensitivity Glasgow prognostic score and infection-related mortality in maintenance hemodialysis patients: 10-year outcomes of the Q-Cohort Study.

  Clin Exp Nephrol in press

• Yamada S, Arase H, Tokumoto M, Taniguchi M, Tsuruya K, Kitazono T, Nakano T.

  Nutritional status modifies cause-specific mortality risk associated with higher serum calcium levels in patients undergoing hemodialysis: The Q-cohort Study.

  Clin Nutr ESPEN in press

• Haruyama N, Nakayama M, Tanaka S, Tsuda S, Yoshitomi R, Fukui A, Tsuruya K, Kitazono T, Nakano T.

  Prognostic Value of Controlling Nutritional Status Score and Prognostic Nutritional Index for All-Cause Mortality in Patients with Chronic Kidney Disease: The Fukuoka Kidney Disease Registry Study.

  J Nutr. 2026 Jan;156(1):101231.

• Kuwahara F, Harada K, Nagata M, Nakano T, Ago T, Kanai H.

  Zinc deficiency is associated with erythropoietin-stimulating agents hyporesponsive anemia in peritoneal dialysis patients: a cross-sectional study.

  Clin Exp Nephrol. 2026 Apr;30(4):661-669.

• Okamoto H, Matsukuma Y, Ataka E, Ueki K, Tsuchimoto A, Masutani K, Noguchi H, Kaku K, Yamada S, Nakamura M, Nakano T, Ago T.

  Synergistic effect of obesity on hypertensive renal arteriosclerosis in individuals without chronic kidney disease: A zero-hour biopsy-based cohort study.

  Hypertens Res. 2026 Apr;49(4):1371-1381.

症例報告

• Yamada S, Enomoto S, Matsuo K, Sonezaki Y, Torisu K.

  Denosumab increased bone mineral density but caused marked serum calcium fluctuations in a patient undergoing peritoneal dialysis.

  CEN Case Rep. 2026 Jun 30;15(4):114.

• Minami Y, Ueki K, Mito M, Torisu K, Yamada S, Tsuneyoshi S, Fujino T, Taniguchi M, Narutomi F, Tateishi Y, Oda Y, Tasaki M, Ueda M, Kitazono T, Nakano T.

  A Case of Amyloid Arthritis With Increased Amyloid Deposition of Both β2-Microglobulin and Transthyretin Before Reinitiating Dialysis Long After Kidney Transplantation.

  Nephrology (Carlton). 2026 Feb;31(2):e70162.

その他

• Yamada S, Arase H, Matsueda S, Ago T.

  A Calciprotein Particle-Centric Framework for Vascular Calcification in CKD Models.

  J Am Soc Nephrol 2026;37(4):897-898.